43
In band
Moving averages
SMA 200$97.63-1.95%
Company profile
BioNTech SE, a biotechnology company, develops and markets immunotherapies for cancer and other infectious diseases. The company is headquartered in Mainz, Germany.
SectorHealthcare
IndustryBiotechnology
Market cap$24.30B
P/E ratioNone
EPS$-7.83
Beta1.293
Dividend yield0.00%
52-week high$124.00
52-week low$79.52
Similar stocks in Biotechnology
VRTX
Vertex Pharmaceuticals Inc
RSI 38
CRSP
CRISPR Therapeutics AG
RSI 46
IOVA
Iovance Biotherapeutics Inc
RSI 66
MRNA
Moderna Inc
RSI 60
VKTX
Viking Therapeutics Inc
RSI 39
SRPT
Sarepta Therapeutics Inc
RSI 37
EDIT
Editas Medicine Inc
RSI 49
IBRX
ImmunityBio Inc
RSI 61
NVAX
Novavax Inc
RSI 60
DNA
Ginkgo Bioworks Holdings Inc - Class A
RSI 63
RSI alerts for BNTX
Get an email the moment BioNTech SE crosses into oversold or overbought territory. Nothing else, ever.
Add alertData last updated 13 September 2026 at 1:56 AM EDT